Evidence review

Recovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `recovery-stack-intro`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/recovery-stack-intro

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/recovery-stack-intro/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/recovery-stack-intro/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/recovery-stack-intro/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/recovery-stack-intro/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Degenerative disc disease

  1. The disc is mostly water and collagen. Over time it loses height and hydration.
  2. Less hydration → less shock absorption → more load on joints and nerves.
  3. Micro-tears accumulate. The body cannot repair as fast as load breaks tissue down.
  4. That is degeneration: breakdown outruns regeneration.

Layers:

  • Disc matrix: Collagen and proteoglycans degrade; disc height drops.
  • Inflammation: Chronic inflammatory signaling without resolution stalls repair.
  • Nerves: Nerve roots get irritated or compressed as disc bulges.
  • Blood supply: Discs are avascular — repair depends on diffusion; less supply = slower repair.

Why BPC-157 might help you

  1. You have Degenerative disc disease — breakdown is outpacing repair.
  2. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  3. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  4. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why TB-500 might help you

  1. You have Degenerative disc disease — breakdown is outpacing repair.
  2. Layer breaking down: Inflammation — Chronic inflammatory signaling without resolution stalls repair.
  3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  4. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

Why ARA-290 might help you

  1. You have Degenerative disc disease — breakdown is outpacing repair.
  2. Layer breaking down: Nerves — Nerve roots get irritated or compressed as disc bulges.
  3. What ARA-290 is studied to do: Studied for nerve repair and small-fiber regeneration in neuropathy models.
  4. Therefore for you: If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.

How these fit together

Three degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.

  • BPC-157 → structure / tissue
  • TB-500 → inflammation clearance / repair-cell migration
  • ARA-290 → nerve / innervation

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 10
  • Claims tagged human evidence: 7
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 19
  • Reddit posts catalogued: 14
  • X posts catalogued: 4
  • Other anecdote sources (YouTube, Instagram, etc.): 1
  • Total sources in chain: 30

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing (source s1)

Reviews BPC-157 effects on multiple tissues including angiogenesis in animal models.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (source s2)

Documents lack of robust human RCTs for BPC-157 in injuries.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Thymosin β4: a multi-functional regenerative peptide (source s3)

Mechanistic and preclinical overview of thymosin beta-4 actions.

Evidence type: Published research.

Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy (source s4)

Human trial data on nerve regrowth and symptom improvement.

Evidence type: Published research.

Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts (source s5)

Discusses BPC-157's role in tendon healing and growth hormone receptor expression in preclinical studies.

Evidence type: Published research.

ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes (source s6)

Human clinical data on ARA-290 for neuropathic symptoms in diabetes patients.

Evidence type: Published research.

ARA-290: Neuropathic Pain & Nerve Repair (source s10)

Discusses rationale for combining ARA-290 with BPC-157 and TB-500 for nerve issues in injuries.

Evidence type: Published research.

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians (source s11)

2026 narrative review discussing BPC-157 and TB-500 for orthopaedic use; notes limited human evidence and preclinical promise for injury recovery.

Evidence type: Published research.

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions (source s12)

2026 review on peptides including BPC-157 and TB-500 in orthopaedics, highlighting mechanisms for tissue repair but lack of human trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

BPC 157 for Acute Hamstring Muscle Strain Repair (source s13)

Ongoing 2026 Phase 2 RCT for BPC-157 in hamstring injury recovery; first such trial mentioned for musculoskeletal use.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Peptide ARA-290 — Reddit, r/neuropathy (source s7)

User anecdote on stacking ARA-290 with BPC-157 and TB-500 for neuropathy improvement.

BPC-157, TB-500, and ARA-290 stack — Reddit, r/Peptides (source s14)

Reddit anecdote discussing stacking BPC-157 + TB-500 + ARA-290 for post-surgery nerve damage and recovery.

The Peptide Hiding in Plain Sight for Nerve Health — Reddit, r/BioHackingGuide (source s15)

Reddit post on ARA-290 for neuropathy, mentioning stacks with BPC-157 and TB-500 for injury/nerve recovery.

Effectiveness of ARA-290...My Assessment — Reddit, r/smallfiberneuropathy (source s16)

User reports BPC-157 + TB-500 did not help and may have coincided with worsening neuropathy symptoms, leading to trying ARA-290 instead; another commenter notes BPC/TB helpful only for small injuries, not large ones.

BPC-157 for long term nerve damage? — Reddit, r/BodyHackGuide (source s17)

User reports BPC-157 + TB-500 stack resolved chronic feet pain/numbness/tingling; positive anecdotal outcome for nerve-related foot issues.

ARA-290, whats your experience? — Reddit, r/neuropathy (source s20)

User reports no effect from 4mg daily ARA-290 for 8 weeks on neuropathy (anecdotal, not advice). Another comment: 'Same 4mg/day for 60 days no effect on my 10 yr idiopathic peripheral neuropathy' (bad outcome, anecdot….

ARA 290 and BPC 157 — Reddit, r/floxies (source s21)

User tolerated BPC-157 (250mcg 2x daily, 20 days) without issues but TB-500 caused flare (bad outcome, anecdotal, not advice). Discusses stacking interest with ARA-290 for nerve issues and inflammation; magnesium sens….

Peptides to help? — Reddit, r/Biohacking (source s22)

Comment suggests stacking BPC-157, KPV, ARA-290 daily with TB-500 every 2-3 days for healing/inflammation (dosing anecdote, not advice). Post discusses BPC-157/TB-500 for soft tissue and ARA-290 for nerves.

ARA-290 Might Be the Most Slept On Peptide for Nerve ... — Reddit, r/BioHackingGuide (source s23)

Discussion of ARA-290 for nerves alongside known BPC-157 + TB-500 stack (anecdotal interest in stacking, not advice).

Can I add ARA-290 to a BPC-157 and TB-500 stack? — Reddit, r/Peptides (source s24)

User inquires about adding 4mg daily ARA-290 to BPC-157/TB-500 stack for neuropathic pain post-surgery (dosing anecdote/query, not advice). Notes usual BPC + TB stack and interest in ARA-290 addition.

Slipped disc repair — Reddit, r/bpc_157 (source s25)

User reports positive anecdotal experience with BPC/TB-500 (and mentions prior ARA-290 cycles) for disc issues and pain; another notes BPC/TB4/ARA-290 cycles but emphasizes time as main factor. Anecdotal, not advice. ….

ARA-290 (Cibinetide) Explained: The Nerve Repair Peptide Most Recovery Stacks Miss — Reddit, r/PeptideGuide (source s26)

Post explains stacking rationale for complex injuries; comments include dosing anecdotes (1-4mg subQ daily/3-5x week, clinical 4mg). No specific user outcomes reported here. Anecdotal discussion only.

Has anyone tried ARA-290? Does it help with healing like ... — Reddit, r/Peptides (source s27)

Thread asks about adding ARA-290 to BPC/TB-500 stack for neuropathic pain post-surgery. Anecdotal inquiry on synergy/side effects/dosing.

Anyone try peptides to speed up healing? — Reddit, r/hysterectomy (source s30)

Comments discuss BPC+TB-500+ARA-290 for healing/inflammation post-surgery. Anecdotal recommendations and one user planning BPC+TB-500 stack.

What people say on X

X post on ARA-290 + TB-500 + BPC-157 stack — X (source s18)

User reports positive outcomes from stacking ARA-290 with TB-500 and BPC-157: improved nerve function, mobility, and soft tissue healing from rugby injuries/pinched nerves.

X post on ARA-290 experience — X (source s19)

User notes ARA-290 pairs effectively with BPC-157 + TB-500 for nerve repair (after discussing dosing and timeline for ARA-290).

Modified stack for early airport day... — X (source s28)

User mentions daily use of ARA-290 + BPC-157 + TB-500 stack in recovery context. Anecdotal dosing/protocol mention, no specific outcomes or side effects detailed.

🩹 ARA-290 Peps 🔬 My personal experience ... — X (source s29)

Personal experience post on ARA-290 benefits for inflammation/nerve repair/recovery, recommends pairing with BPC-157 (implies TB-500 context in stack discussions). Anecdotal positive outcomes reported.

What we do not know

  1. Synergistic effects of BPC-157 + TB-500 + ARA-290 in complex injuries have not been tested in human trials.
  2. There are no human trials examining the synergistic effects of BPC-157, TB-500, and ARA-290 for complex injuries.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →
TB-500: Thymosin Beta-4 · inflammation clearance / repair-cell migration · tb-500
{
  "peptide": "tb-500",
  "regenerative_layer": "inflammation clearance / repair-cell migration",
  "targets_this_degeneration": "Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.",
  "proposed_regeneration": "Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.",
  "evidence_in_ledger": {
    "human_claims": 14,
    "preclinical_claims": 4,
    "anecdote_claims": 74,
    "studies_catalogued": 25
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/tb-500"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and rebuilds it at the same time. When breakdown stays ahead of repair, injury or disease persists. Most drugs block signals such as pain or swelling without rebuilding the tissue that created the signal. TB-500 is studied for repair pathways: i…

Full tb-500 article →
ARA-290: Nerve Repair Peptide · nerve / innervation · ara-290
{
  "peptide": "ara-290",
  "regenerative_layer": "nerve / innervation",
  "targets_this_degeneration": "Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.",
  "proposed_regeneration": "Studied for nerve repair and small-fiber regeneration in neuropathy models.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 1,
    "anecdote_claims": 45,
    "studies_catalogued": 21
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/ara-290"
}

Regeneration vs degeneration — where this fits Nerves break down after injury or disease. Small fiber neuropathy is one case where breakdown outruns repair. Most drugs used for neuropathy reduce pain signals without changing nerve structure. ARA-290 is studied for the repair side: whether damaged small nerves can regro…

Full ara-290 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

BPC 157 · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBPC-157: Body Protection Compound · 24 humanAging Repair Stack: BPC-157 + TB-500 + GHK-Cu · 12 humanBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Review · 7 humanBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid… · 6 human
Evidence · 30 sources · swipe →chain d7a92e4fa35d · verify chain · provenance
1 / 30
Evidence ledger 30 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
system
Recovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290 is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
anecdotal
User notes ARA-290 pairs effectively with BPC-157 + TB-500 for nerve repair (after discussing dosing and timeline for ARA-290).
sources: s19
human
BPC-157 promotes new blood vessel formation into damaged tendon, gut, muscle, bone, and nerve tissues in animal and cell studies.
sources: s1
human
No large randomized controlled human trials demonstrate BPC-157 efficacy for musculoskeletal injuries.
sources: s2
23 more ranked claims
human0.22
Synergistic effects of BPC-157 + TB-500 + ARA-290 in complex injuries have not been tested in human trials.
grok/4.3-populate
Highlights absence of combination data.
sources: s2
human0.22low confidence
2026 review on peptides including BPC-157 and TB-500 in orthopaedics, highlighting mechanisms for tissue repair but lack of human trials.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
human0.22low confidence
Ongoing 2026 Phase 2 RCT for BPC-157 in hamstring injury recovery; first such trial mentioned for musculoskeletal use.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
human0.22
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.22
There are no human trials examining the synergistic effects of BPC-157, TB-500, and ARA-290 for complex injuries.
kimi-collaborator
This claim explicitly states a gap in knowledge regarding the lack of human trials for the combined effects of the Recovery Stack, which is a critical piece of information missing from the ledger.
sources: s2
anecdotal0.22low confidence
User anecdote on stacking ARA-290 with BPC-157 and TB-500 for neuropathy improvement.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
anecdotal0.22low confidence
Anecdotal report of the three-peptide stack for post-surgery recovery.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Reddit anecdote discussing stacking BPC-157 + TB-500 + ARA-290 for post-surgery nerve damage and recovery.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
Reddit post on ARA-290 for neuropathy, mentioning stacks with BPC-157 and TB-500 for injury/nerve recovery.
grok/grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
Anecdotal reports from Reddit user and Instagram post claim improved neuropathy symptoms and post-surgery recovery with the use of BPC-157, TB-500, and ARA-290.
kimi-collaborator
These claims identify the sources of anecdotal evidence, providing transparency on who is making these claims, which was missing from the ledger.
sources: s7, s8
anecdotal0.22
User reports BPC-157 + TB-500 did not help and may have coincided with worsening neuropathy symptoms, leading to trying ARA-290 instead; another commenter notes BPC/TB helpful only for small injuries, not large ones.
grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
User reports BPC-157 + TB-500 stack resolved chronic feet pain/numbness/tingling; positive anecdotal outcome for nerve-related foot issues.
grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22low confidence
User reports positive outcomes from stacking ARA-290 with TB-500 and BPC-157: improved nerve function, mobility, and soft tissue healing from rugby injuries/pinched nerves.
grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User reports no effect from 4mg daily ARA-290 for 8 weeks on neuropathy (anecdotal, not advice). Another comment: 'Same 4mg/day for 60 days no effect on my 10 yr idiopathic peripheral neuropathy' (bad outcome, anecdotal). Post mentions positive prior experience with BPC-157 + TB-500 stack.
grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22low confidence
User tolerated BPC-157 (250mcg 2x daily, 20 days) without issues but TB-500 caused flare (bad outcome, anecdotal, not advice). Discusses stacking interest with ARA-290 for nerve issues and inflammation; magnesium sensitivity noted as side effect trigger.
grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22low confidence
Comment suggests stacking BPC-157, KPV, ARA-290 daily with TB-500 every 2-3 days for healing/inflammation (dosing anecdote, not advice). Post discusses BPC-157/TB-500 for soft tissue and ARA-290 for nerves.
grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22low confidence
Discussion of ARA-290 for nerves alongside known BPC-157 + TB-500 stack (anecdotal interest in stacking, not advice).
grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22low confidence
User inquires about adding 4mg daily ARA-290 to BPC-157/TB-500 stack for neuropathic pain post-surgery (dosing anecdote/query, not advice). Notes usual BPC + TB stack and interest in ARA-290 addition.
grok-4.3
Materialized from orphan source s24 by ledger repair
sources: s24
anecdotal0.22low confidence
User reports positive anecdotal experience with BPC/TB-500 (and mentions prior ARA-290 cycles) for disc issues and pain; another notes BPC/TB4/ARA-290 cycles but emphasizes time as main factor. Anecdotal, not advice. Dosing example: 250mcg BPC daily then 2x/day.
grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
Thread asks about adding ARA-290 to BPC/TB-500 stack for neuropathic pain post-surgery. Anecdotal inquiry on synergy/side effects/dosing.
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22low confidence
User mentions daily use of ARA-290 + BPC-157 + TB-500 stack in recovery context. Anecdotal dosing/protocol mention, no specific outcomes or side effects detailed.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22low confidence
Personal experience post on ARA-290 benefits for inflammation/nerve repair/recovery, recommends pairing with BPC-157 (implies TB-500 context in stack discussions). Anecdotal positive outcomes reported.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
Comments discuss BPC+TB-500+ARA-290 for healing/inflammation post-surgery. Anecdotal recommendations and one user planning BPC+TB-500 stack.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
Low-confidence / auto-generated 2
speculative0.12low confidence
Commercial vendors and clinics market this compound (7 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 10 duplicate marketing claims
sources: s3, s4, s5, s6, s9, s11, s26
speculative0.12low confidence
Discusses rationale for combining ARA-290 with BPC-157 and TB-500 for nerve issues in injuries.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
Model swipes · 13 from 5 models · swipe →verify
1 / 13
grok/grok-4.3writer
redraft2026-06-29 08:59
Recovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290 · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "recovery-stack-complex-injuries-bpc-157-tb-500-ara-290",
  "title": "Recovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290",
  "body": "## Overview of Complex Injury Layers\nComplex injuries involve overlapping tissue damage, persistent inflammation, and nerve involvement. Standard approaches often target isolated aspects.\n\n## BPC-157: Local Tissue Angiogenesis\nBPC-157 is a synthetic 15-amino-acid peptide derived from gastric juice protein. In over 100 animal and cell studies, it has been associated with formation of new blood vessels into damaged sites including tendon, gut, muscle, bone, and nerve tissues (preclinical tier). No large randomized human trials for musculoskeletal injuries exist (no human data for efficacy claims).\n\n## TB-500: Systemic Repair Cell Mobilization\nTB-500 is a synthetic version of thymosin beta-4. Preclinical studies indicate it promotes migration of repair cells to injury sites and modulates inflammatory signaling without broad suppression (preclinical tier). Endogenous production declines with age (mechanistic tier).\n\n## ARA-290: Nerve Fiber Regrowth\nARA-290 targets the innate repair receptor. Human clinical trials in sarcoidosis and diabetes patients have shown improved neuropathic symptoms and corneal small nerve fiber regrowth after 28 days of treatment (human tier). It does not mask pain signals (human tier).\n\n#
00b85b7654b630f8
grok-4.3source_hunt
sources2026-06-29 10:43
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
5 source(s) added
6e60b65bd1040c15
grok-4.3source_hunt
sources2026-06-29 10:43
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
5 source(s) added
0577e9ca7643b735
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
{"materialized":0,"before":[],"after":[]}
89978836bc89e33d
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
{"materialized":0,"before":[],"after":[]}
aa5cfab44106d6d0
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
{"materialized":0,"before":[],"after":[]}
1b846c60000413fa
system/audit-repairclaim_post
claim2026-06-29 12:48
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
{"materialized":0,"before":[],"after":[]}
d218023e6e13098f
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:58
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
I added explicit gaps regarding the lack of human trials for the synergistic effects of the Recovery Stack and named who claims what from anecdotes, as instructed.
d492febbd89ff438
grok-4.3source_hunt
sources2026-06-29 16:00
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
4 source(s) added
ea5782ef5f761bdf
grok-4.3source_hunt
sources2026-06-29 18:05
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
5 source(s) added
79a312ad6bbd3b93
grok-4.3source_hunt
sources2026-06-29 18:06
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro
it output
6 source(s) added
4977f1c331168658
fill-slotsclaim_post
claim2026-06-29 20:57
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro c39
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
1c3c645d15697671
fill-slotsclaim_post
claim2026-06-29 20:57
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: recovery-stack-intro c39
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
db311a358b6d5473

Related research

BPC 157 · peptide map

Open evidence map →
BPC-157: Body Protection Compoundembedded in this articlebpc-157TB-500: Thymosin Beta-4embedded in this articletb-500ARA-290: Nerve Repair Peptideembedded in this articleara-290Aging Repair Stack: BPC-157 + TB-500 + GHK-Cuaging-stack-introBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid…bpc-157-adderall-gutBPC 157 for Benzo Withdrawalbpc-157-benzo-withdrawalBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Reviewbpc-157-benzo-withdrawal-gutBPC 157 for Benzodiazepinesbpc-157-benzodiazepinesBPC 157 for Brain Fogbpc-157-brain-fogBPC 157 for Carpal Tunnelbpc-157-carpal-tunnel
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask recovery-stack-intro claim c39 · paste includes §SELF
What does the ledger say about this (system tier): "Recovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290 is catalogued in this miscsubjects ledger as a tier-honest evidence graph (c…"?
ask recovery-stack-intro claim c38 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "User notes ARA-290 pairs effectively with BPC-157 + TB-500 for nerve repair (after discussing dosing and timeline for ARA-290)."?
ask recovery-stack-intro claim c26 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask recovery-stack-intro claim c20 · paste includes §SELF
What does the ledger say about this (human tier): "BPC-157 promotes new blood vessel formation into damaged tendon, gut, muscle, bone, and nerve tissues in animal and cell studies."?
ask recovery-stack-intro claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No large randomized controlled human trials demonstrate BPC-157 efficacy for musculoskeletal injuries."?
ask recovery-stack-intro claim c2 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on stacking ARA-290 with BPC-157 and TB-500 for neuropathy improvement."
ask recovery-stack-intro source s7 · paste includes §SELF
Summarize this instagram report and how it should weigh: "Anecdotal report of the three-peptide stack for post-surgery recovery."
ask recovery-stack-intro source s8 · paste includes §SELF
recovery-stack-intro · posted 2026-06-29 · updated 2026-06-29 · 18 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 18 model passes · 3503 tokens · $0 · 6 models
chain head e66e8adbc2c83afc
write grok/grok-4.3 · 2026-06-29 08:59 · 0 tok · ae398392e726
sources grok-4.3 · 2026-06-29 10:43 · 0 tok · e702f35b8449
sources grok-4.3 · 2026-06-29 10:43 · 0 tok · 2497887f38c2
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · d230700e583e
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · a4a07d363e3f
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · d8d636f4dc96
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · fe6f12639662
claim system/audit-repair · 2026-06-29 12:48 · 0 tok · 4fe071080b91
repair system/audit-repair · 2026-06-29 12:48 · 0 tok · 786f3d894088
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · a9162ca80f9b
repair system/audit-repair · 2026-06-29 13:23 · 0 tok · a222d3f8aca9
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:58 · 3503 tok · 03a69a757d3d
sources grok-4.3 · 2026-06-29 16:00 · 0 tok · e90860571293
sources grok-4.3 · 2026-06-29 18:05 · 0 tok · a3b60d358961
sources grok-4.3 · 2026-06-29 18:06 · 0 tok · 5d15ceca317b
repair repair · 2026-06-29 19:46 · 0 tok · b6a201703259
claim fill-slots · 2026-06-29 20:57 · 0 tok · 1e0733a66bb6
claim fill-slots · 2026-06-29 20:57 · 0 tok · e66e8adbc2c8
verify chain →
Live ledger · 34 payloads · 8 turns
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 18:07 · t_cg98h2i5
PROTOCOL_RUN dispatch · 2026-06-29 18:07 · t_cg98h2i5
PROTOCOL_RUN dispatch · 2026-06-29 18:06 · t_0scyzjgq
PROTOCOL_RUN dispatch · 2026-06-29 18:06 · t_0scyzjgq
webhook_in blooio · 2026-06-29 18:06
webhook_in blooio · 2026-06-29 18:06
view full ledger & cards →
REST + ledger
read GET /api/articles/recovery-stack-intro · GET /api/articles/recovery-stack-intro?format=post (the editable body)
create/replace POST /api/articles/recovery-stack-intro · PUT /api/articles/recovery-stack-intro (replace, keeps revision) · PATCH /api/articles/recovery-stack-intro (merge)
delete DELETE /api/articles/recovery-stack-intro
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/recovery-stack-intro/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/recovery-stack-intro/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim recovery-stack-intro|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →